Pacific Edge will be ‘juicy nugget’ for purchase: David Darling

Cancer diagnostics company Pacific Edge [NZX: PEB] is probably being closely watched by bigger US medical companies waiting for a ripe opportunity to acquire, its chief executive David Darling believes.

The Dunedin-based company – which makes bladder cancer detection tests and has just got a US patent to develop melanoma detection technology – is making progress towards its US domination plans.


Want to read more?

Choose a Subscription type that's right for you HERE
Already have an account? Login